granules

  1. Granules India promoter sells 3.09 pc stake for Rs 304 crore

    Granules India promoter sells 3.09 pc stake for Rs 304 crore

    New Delhi: Krishna Prasad Chigurupati, one of the promoters of Granules India, on Wednesday sold 3.09 per cent stake in the company for Rs 304 crore through an open market transaction.According to block deal data available on NSE, Krishna Prasad Chigurupati sold 75 lakh shares, equivalent to...
  2. Granules India's fourth quarter profit increases by 8 percent to Rs 130 crore

    Granules India's fourth quarter profit increases by 8 percent to Rs 130 crore

    New Delhi, Drug firm Granules India on Wednesday reported 8 per cent rise in consolidated profit after tax at Rs 130 crore for the fourth quarter ending March 31, 2024.The pharmaceutical company had reported a profit after tax (PAT) of Rs 120 crore for January-March FY23.Revenue from...
  3. Granules gets USFDA approval for generic gout drug

    Granules gets USFDA approval for generic gout drug

    New Delhi: Drug firm Granules India on Tuesday said it has received approval from the US health regulator to market a drug used to prevent or treat arthritis attacks.The company's wholly owned foreign subsidiary, Granules Pharmaceuticals, Inc., has received approval from the US Food and Drug...
Back
Top